Pages that link to "Q37950862"
Jump to navigation
Jump to search
The following pages link to Metabolic oligosaccharide engineering: implications for selectin-mediated adhesion and leukocyte extravasation. (Q37950862):
Displaying 8 items.
- Identification of sialylated glycoproteins from metabolically oligosaccharide engineered pancreatic cells (Q35615401) (← links)
- Sialidases as regulators of bioengineered cellular surfaces. (Q35678457) (← links)
- Metabolic glycoengineering bacteria for therapeutic, recombinant protein, and metabolite production applications (Q38452524) (← links)
- Harnessing cancer cell metabolism for theranostic applications using metabolic glycoengineering of sialic acid in breast cancer as a pioneering example (Q39031683) (← links)
- Metabolic flux-driven sialylation alters internalization, recycling, and drug sensitivity of the epidermal growth factor receptor (EGFR) in SW1990 pancreatic cancer cells. (Q42177413) (← links)
- Pharmacological, Physiochemical, and Drug-Relevant Biological Properties of Short Chain Fatty Acid Hexosamine Analogues Used in Metabolic Glycoengineering. (Q47739066) (← links)
- A novel sugar analog enhances sialic acid production and biotherapeutic sialylation in CHO cells. (Q48126423) (← links)
- Integration of genetic and metabolic features related to sialic acid metabolism distinguishes human breast cell subtypes. (Q54977678) (← links)